Basit öğe kaydını göster

dc.contributor.authorSahin, Serdar
dc.contributor.authorOsar Siva, Zeynep
dc.contributor.authorTutuncu, Mesude
dc.contributor.authorPolat Korkmaz, Ozge
dc.contributor.authorOzer, Melis Dila
dc.contributor.authorHaliloglu, Ozlem
dc.date.accessioned2021-03-03T14:44:07Z
dc.date.available2021-03-03T14:44:07Z
dc.date.issued2020
dc.identifier.citationHaliloglu O., Tutuncu M., Sahin S., Polat Korkmaz O., Ozer M. D. , Osar Siva Z., "Fatigue is Related to Insulin Use by Acting Via Depressive Mood in Patients with Diabetes Mellitus", TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, cilt.24, sa.1, ss.29-37, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_3b27093c-eadf-48d4-879f-857fe4989af6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/43724
dc.identifier.urihttps://doi.org/10.25179/tjem.2019-71576
dc.description.abstractObjective: Fatigue is a common symptom in diabetes mellitus. The aim of this study was to determine the factors leading to fatigue and to investigate the effect of insulin use on fatigue among the diabetic population. Material and Methods: One-hundred diabetic patients attending the diabetes clinic of Cerrahpasa Medical Faculty between October 2017-January 2018 and 42 healthy controls were evaluated in this cross-sectional study. Questionnaires including demographic and disease characteristics, Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), quality of life scale (SF-36), Epworth Sleepiness Scale (ESS), and Pittsburgh Sleep Quality Index (PSQI) were used. Results: Ages (47.6 +/- 14.8 and 45.7 +/- 14.1 years; p=0.47) and body mass indices (26.6 +/- 4.1 and 25.3 +/- 3.5 kg/m(2); p=0.08) of 100 patients with diabetes (Type 1 Diabetes/Type 2 Diabetes=29/71) and 42 healthy volunteers were similar. The diabetic group had worse FIS total (p=0.05), FIS psychological (p=0.04) scores and SF-36 scores compared to the healthy controls. When the patients with diabetes were divided into two groups according to insulin use and compared with healthy controls, the ESS and PSQI were similar but all FIS parameters (total p=0.005, cognitive p=0.007, physical p=0.01, psychological p=0.009) and BDI (p=0.05) were significantly worse in patients with insulin use than non-insulin and control groups. The relationship between fatigue and insulin use was independent of glycemic control and duration of diabetes but was affected by the BDI (p=0.001). Conclusion: Insulin use leads to fatigue in patients with diabetes, regardless of diabetes type, and this effect is influenced by depressive mood. Psychotherapeutic approaches prior to insulin treatment might yield fruitful results.
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleFatigue is Related to Insulin Use by Acting Via Depressive Mood in Patients with Diabetes Mellitus
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , ,
dc.identifier.volume24
dc.identifier.issue1
dc.identifier.startpage29
dc.identifier.endpage37
dc.contributor.firstauthorID2278627


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster